Steve Oldfield has been appointed to a newly-created post of chief commercial officer for the Department of Health with the task of improving delivery and cost performance.
Oldfield, who will take up the position in October, will begin with the “creation and development of the commercial strategy that will underpin upcoming negotations with a variety of commercial suppliers”.
This includes engagement with the drugs industry over the Pharmaceutical Price Regulation Scheme (PPRS), under which prices for medicines are agreed between firms and the DoH. The government spends around £8bn a year under the PPRS.
The Cabinet Office said Oldfield will “lead the development of commercial capability and sharing of commercial best practice across the wider health family to the benefit of the whole system”. He will be “tasked with improving the delivery and cost performance of our supply chain”.
Oldfield has worked in the healthcare industry for 25 years and is currently chief operating officer at PGT, a consumer health joint venture between Procter & Gamble and Teva.
He will report functionally to Gareth Rhys Williams, the government’s chief commercial officer.
Oldfield said: “Demands on the health system have never been greater, and I hope to be able to bring my previous commercial experience to bear on the activities of the department.
“In particular, I look forward to working collaboratively across the department, the NHS and the life sciences to find new ways of working for the benefit of patients and the health economy.”
Rhys Williams said: “He brings deep knowledge of the pharmaceutical industry, which will be very valuable as we start to work with them on the next iteration of the £8bn per annum medicines pricing scheme.”
☛ Want to stay up to date with the news? Sign up to our daily bulletin.